Ketaset® 100 mg/mL Ketamine Injection – 10 mL Vial

Ketaset® 100 mg/mL Ketamine Injection provides veterinary professionals with a standardized ketamine hydrochloride formulation for specific anesthetic applications. Zoetis manufactures Ketaset as a sterile injectable solution, and each 10 mL vial contains 100 mg/mL of ketamine base, equivalent to 1,000 mg of ketamine base per vial.

Ketaset serves the veterinary market and carries prescription and controlled-substance requirements. Therefore, licensed veterinary professionals should handle, administer, and obtain the product according to applicable regulations.

Veterinary Use Overview

The Ketaset 10 mL vial offers a clearly defined concentration for veterinary practices that require ketamine hydrochloride injection. According to the U.S. product labeling, veterinarians can use Ketaset in cats for restraint and as a sole anesthetic for diagnostic procedures or minor, brief surgical procedures that do not require skeletal muscle relaxation. The label also includes restraint use in nonhuman primates.

Because ketamine can produce significant physiological effects, veterinary professionals should evaluate every animal before administration. In addition, appropriate monitoring during anesthesia and recovery remains essential.

Product Specifications

• Brand: Ketaset®
• Active ingredient: Ketamine hydrochloride
• Strength: 100 mg/mL
• Vial size: 10 mL
• Total ketamine: 1,000 mg per 10 mL vial
• Dosage form: Sterile injectable solution
• Manufacturer: Zoetis
• Product type: Veterinary anesthetic
• U.S. approval: NADA 043-304
• Regulatory classification: Veterinary prescription/controlled substance

Clinical Considerations

Ketaset offers a consistent ketamine formulation with established veterinary labeling. Furthermore, its clearly stated 100 mg/mL concentration and 10 mL vial size make product identification straightforward for authorized veterinary practices.

Veterinary professionals should always consider the animal’s condition, procedure, and other relevant clinical factors before selecting an anesthetic. They should also maintain appropriate monitoring and emergency-support capabilities throughout anesthesia and recovery.

Quality, Handling, and Safety

Ketaset comes as a sterile injectable veterinary formulation. Before use, veterinary professionals should inspect the vial and confirm that the product meets the manufacturer’s specifications.

Moreover, veterinarians should review the complete prescribing information before administration. The official labeling describes potential adverse reactions associated with ketamine, including respiratory depression, vomiting, salivation, vocalization, irregular or prolonged recovery, tremors, convulsions, breathing difficulties, and cardiovascular effects.

For this reason, qualified veterinary professionals should administer Ketaset in an appropriate clinical setting. They should also follow the manufacturer’s instructions for storage, handling, administration, contraindications, warnings, and precautions.

Availability for Veterinary Practices

The Ketaset 100 mg/mL 10 mL vial provides a standardized veterinary ketamine formulation for approved applications. Each vial contains 10 mL of solution at 100 mg/mL, giving a total of 1,000 mg of ketamine base.

However, Ketaset remains a regulated veterinary product. Therefore, veterinary practices should purchase it through authorized pharmaceutical channels and follow all applicable prescription and controlled-substance requirements.

Ordering Information

If your veterinary practice requires Ketaset 100 mg/mL 10 mL vials, speak with a licensed veterinarian or authorized veterinary pharmaceutical distributor about availability and purchasing requirements.

Important: Ketaset is a veterinary product and is not intended for human use. Always follow the current manufacturer labeling and applicable federal, state, and local regulations.